Egon Zehnder
Suche
Select region
Close filter

Christopher Pfeiffer

Kontakt

+1 972 728 5910

Kontakt

Christopher Pfeiffer, based in Dallas, is a trusted advisor to health-care and private-equity firms, with particular expertise in R&D, strategy, finance, and supply-chain management in the pharmaceutical, technology, and manufacturing industries. He also provides talent and succession consulting as well as executive assessment and development services to boards, CEOs, and executive teams.

There is an industrial revolution going on in health care today, and I feel privileged to have a front-row seat.

Prior to joining Egon Zehnder, Christopher was a Vice President at CSC Index Management Consultants, based in Dallas, where he managed large-scale strategy, operations improvement, and technology engagements for Fortune 500 industrial and health-care clients. His previous roles included Senior Director of Business Planning at PepsiCo in Dallas, Vice President of Planning and Marketing at the Children’s Medical Center of Dallas, Engagement Manager with McKinsey & Company in Dallas, and Manufacturing Process Engineer at Intel in Santa Clara, California.

Christopher earned a BSE in industrial engineering from the University of Illinois at Chicago and an MBA in finance from Stanford University. He is passionate about his family, cycling, and participating in triathlons.

Meine Schwerpunkte

Kontakt
E-Mail an Christopher Pfeiffer
Browse all
Interviews, Artikel und Studien

Related Experts Around the Globe

Orsolya Oszabo

Orsolya Oszabo

Budapest

Orsolya Oszabo, based in Budapest, primarily advises clients in Central and Eastern Europe on executive recruitment and C-suite succession… Mehr erfahren

Jacqueline O'Sullivan

Jacqueline O'Sullivan

London

Jackie O’Sullivan, based in London, is a member of Egon Zehnder’s global Assessment and Development practice. Mehr erfahren

Raed Kanaan

Raed Kanaan

Dubai

Raed Kanaan shares his deep financial expertise as an advisor with commercial and investment banks, asset managers, private equity firms, government… Mehr erfahren

Back to top